Labs / Assays & in vitro testing

Space Peptides
Shanghai, China · spacepeptides.com
GMP
Space Peptides is a Swiss-Chinese peptide CRDMO specializing in research, development, and manufacturing from discovery through clinical development to commercial supply. It serves biotech and pharma clients from its headquarters in Bern, Switzerland, and sites in Taizhou, Shanghai, Zhangzhou, and Xiamen in China.
They take quote requests by email.
What they offer
Peptide Drug Discovery & Custom Synthesis
Uses AI-assisted peptide drug discovery to support drug design, optimization, screening, and custom synthesis of peptides and peptide libraries.
Preclinical & Clinical Development
Provides process and analytical development, scale-up, validation, impurity profiling, stability studies, and regulatory services for preclinical and clinical CMC development.
GMP Peptide Manufacturing
Produces high-purity peptides at commercial scale under GMP and environmental standards with access to different reaction vessel sizes.
Client Program Management
Provides project coordination and communication support throughout client engagements.
Generic Peptide API Development
Develops generic peptide APIs focused on peptide actives for obesity, diabetes, osteoporosis, and other women’s health applications.
Target Identification & Validation
Offers AI-powered protein target identification and validation for peptide drug discovery.
Hit Discovery
Uses computerized hit discovery and a proprietary peptide database to screen and design selective peptides.
Testing & Profiling
Provides in-vitro biology assays, in-vivo studies, safety assessments, and AI-driven stability predictions.
Lead Optimization
Uses SAR analysis, test results, and predictive modeling to optimize potency, selectivity, and stability.
Early Formulation
Creates peptide formulations such as gels, tablets, patches, lyophilized and aqueous injections, and prefilled syringes.
API Manufacturing
Supports non-GMP and GMP batch manufacture for preclinical and clinical development.
Process Development
Provides scale-up, process optimization, and validation services for peptide manufacturing processes.
Analytical Development
Offers method development, validation, and stability studies for product characterization and regulatory readiness.
Regulatory Support
Prepares CMC documentation for clinical Phases 1 to 3 and supports regulatory requirements.
Commercial Manufacturing
Provides large-scale GMP peptide manufacturing for commercial supply and product launch.
Filing Support
Assists with regulatory submissions, technical documentation, and response strategies for agency queries.
Peptide Custom Synthesis
Provides rapid access to custom peptide samples, including difficult sequences and modified peptides.
What they work on
- Modalities
- Small molecule, Peptide
- Species and models
- human-inclusive blood analysis, obese, hyperlipidemia, diabetes, MASH, lung cancer, breast cancer, gastric cancer, osteoarthritis, depression, schizophrenia, infections, and 1 more
- Assays and studies
- in-vitro biology assays, in-vivo studies, safety assessments, stability studies, protein target identification and validation, H&E histopathological analysis, biochemical analyses, cell culture, primary cells isolation, WB, IF, FCM, and 3 more
- Instruments and platforms
- LC-MS, HPLC, IR, UV, CEM Liberty Blue microwave peptide synthesizer, DAC preparation liquid phase, ContiChrom continuous flow preparation liquid phase, fully automatic peptide synthesizer
- Scale and capacity
- 1500 kg/a current large scale commissioned GMP SPPS capacity, 5000 kg/a future large scale GMP SPPS capacity, 50 kg/a small scale GMP & non-GMP SPPS capacity, 8000 m² GMP plant area at Taizhou site, 80000 m² site area, 8 peptide production lines, 16 preparative LC units, 16 lyophilizers, 30 analytical instruments, up to five peptide projects in parallel, up to 80-mers, 1.5 MT/a commissioned GMP SPPS capacity, and 3 more
- Therapeutic areas
- obesity, diabetes mellitus type 2, osteoporosis, women’s health, premature labor, heparin-induced thrombocytopenia, thrombosis, septic shock
- Type
- CRDMO
- Sites
- Bern, Switzerland · Shanghai, China · Taizhou, China · Xiamen, China · Zhangzhou, China
- Team
- 100+ employees
- Quality
- cGMP (products, equipment, processes, and global/national guidelines and standards) · GMP (manufacturing and quality control) · quality purity levels often exceeding 99
- Serves
- Europe, Asia Pacific, global
- Address
- 315E Zuchong Zhi Road, 2399 Pudong District, 201210 Shanghai, P.R. China Taizhou Site Space
Similar labs. Porton, ARSI Canada Inc, CordenPharma, Enantia
Found in a contract services directory. Listing built from spacepeptides.com. Work here? Claim this listing.